Close Menu

NEW YORK (GenomeWeb) – Cancer Genetics reported on Tuesday that its fourth quarter revenues fell 9 percent year over year, partially due to the impact on its clinical services business unit from the adoption of new revenues recognition standards at the beginning of 2018.

For the three months ended Dec. 31, 2018, the firm reported total revenues of $6.8 million, down from $7.5 million in the fourth quarter of 2017. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.